Healthcare firm Neocis has received 510(k) clearance from the US Food and Drug Administration (FDA) for the use of its robotic guidance system Yomi during dental implant procedures.
The new device is a computerised navigational system designed to aid in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Yomi provides software to preoperatively plan dental implantation procedures as well as offers navigational guidance of the surgical instruments.
Neocis co-founder and chief executive officer Alon Mozes said: “We are excited to achieve this important milestone for Yomi.
“We look forward to further demonstrating the benefits of Yomi to the surgeon’s practice and their patients and to bringing the system to select key opinion leaders in the US.”
Equipped with the haptic robotic technology, the new system delivers physical guidance for constraining the drill in position, adjusting orientation and depth.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe system is claimed to allow clear visualisation of the surgical site and does not need any custom manufacturing, contrary to plastic surgical guides.
It is said to leave the surgeon in control at all times and offers flexibility during the surgery by providing an option to dynamically change the plan.
According to Center for Specialized Dentistry oral surgeon Dr Federico Grande, the benefits associated with robotic guidance provide comfort to patients regarding the treatment and reliable results.
Though surgical robotics market is enhancing and is expected to reach $20bn by 2021, Yomi is said to be the only surgical robotic system developed for dental industry.
